Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 38483 - pressure alleviation pad, air, alternating contact, - an alternating therapy mattress overlay system designed to facilitate blood circulation and provide maximum body tissue redistribution for treating and prevention of pressure ulcers.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 38483 - pressure alleviation pad, air, alternating contact, - an alternating therapy mattress replacement system designed to facilitate blood circulation and provide maximum body tissue redistribution for treating and prevention of pressure ulcers.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 35225 - pressure alleviation pad, - a low air loss therapy mattress replacement system designed to facilitate blood circulation and provide maximum body tissue redistribution for treating and prevention of pressure sores

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 47479 - alternating-pressure chair cushion system - this is an anti-decubitus air alternating pressure cushion system designed for patients who are at high risk for pressure ulcer to be placed in a variety of mobile devices and potential patients who wish to reduce the likelihood of pressure ulcers. this is a reusable device.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 47478 - alternating-pressure bed mattress overlay system - alternating pressure mattress overlay and alternating pressure control unit pump, designed to assist in the treatment and prevention of pressure injuries

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

k care healthcare solutions pty ltd - 47478 - alternating-pressure bed mattress overlay system - a powered alternating pressure bed mattress, overlay systems. this device is designed to be used as a pressure relieving patient surface for those suffering or managing pressure injuries. mattress overlays & replacements come in varying sizes (differing lengths, widths & heights) to suit users of differing heights or weights and different beds.

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

bowmed ibisqus ltd - clindamycin phosphate - solution for injection - 150mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

bowmed ibisqus ltd - clindamycin phosphate - solution for injection - 150mg/1ml

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ritedose pharmaceuticals, llc - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium inhalation solution usp is a prophylactic agent indicated in the management of patients with bronchial asthma. in patients whose symptoms are sufficiently frequent to require a continuous program of medication, cromolyn sodium inhalation solution usp is given by inhalation on a regular daily basis (see dosage and administration ). the effect of cromolyn sodium is usually evident after several weeks of treatment, although some patients show an almost immediate response. in patients who develop acute bronchoconstriction in response to exposure to exercise, toluene diisocyanate, environmental pollutants, etc., cromolyn sodium should be given shortly before exposure to the precipitating factor (see dosage and administration ). cromolyn sodium inhalation solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium. an aqueous solution for nebulization not for injection for best results, follow these instructions exactly and observe care and storage directions. method of administration cromolyn sodium inhalation solution is recommended for use in a power driven nebulizer operated at an airflow rate of 6-8 liters per minute and equipped with a suitable face mask. hand-operated nebulizers are not suitable for the administration of cromolyn sodium inhalation solution. your doctor will advise on the choice of a suitable nebulizer and how it should be used. do not use any appliance without consulting your doctor. drug stability and safety of cromolyn sodium inhalation solution when mixed with other drugs in a nebulizer have not been established. dosage nebulization should be carried out four times a day at regular intervals, or as directed by your doctor. use the contents of a fresh vial each time. inhalation once the nebulizer has been assembled and contains cromolyn sodium inhalation solution, hold the mask close to the patient’s face and switch on the device. the patient should breathe in through the mouth and out through the nose in a normal, relaxed manner. nebulization should take approximately five to ten minutes. 1. remove a single unit-dose vial from strip (figure 1) figure 1 2. open the unit-dose vial by twisting off the tabbed top section (figure 2). figure 2 3. squeeze the contents of the unit-dose vial into the solution container of your nebulizer (figure 3). discard the empty unit-dose vial. figure 3